Pharmacodynamic Effects of Ranolazine Versus Amlodipine on Platelet Reactivity
Status:
Unknown status
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
No previous study has assessed the potential of ranolazine to interfere with levels of
platelet reactivity in patients with coronary artery disease who are treated with dual
antiplatelet therapy.
Aim of this study is to compare the pharmacodynamic effects of maintenance doses of
ranolazine versus amlodipine on platelet reactivity in patients with coronary artery disease
who are treated with dual antiplatelet therapy.